Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cannabis | 22 | 2024 | 78 | 11.770 |
Why?
|
Smoking | 19 | 2022 | 483 | 4.630 |
Why?
|
Marijuana Use | 8 | 2024 | 36 | 4.610 |
Why?
|
Hallucinogens | 6 | 2022 | 23 | 4.040 |
Why?
|
Electronic Nicotine Delivery Systems | 10 | 2022 | 32 | 3.660 |
Why?
|
Prenatal Care | 11 | 2023 | 128 | 3.630 |
Why?
|
Pregnancy | 28 | 2024 | 1494 | 3.370 |
Why?
|
Pregnant Women | 7 | 2022 | 45 | 3.280 |
Why?
|
Alcohol Drinking | 13 | 2021 | 368 | 3.190 |
Why?
|
Marijuana Smoking | 6 | 2024 | 52 | 3.050 |
Why?
|
Female | 76 | 2024 | 12608 | 2.990 |
Why?
|
Humans | 91 | 2024 | 17611 | 2.880 |
Why?
|
Substance-Related Disorders | 11 | 2022 | 434 | 2.670 |
Why?
|
Intimate Partner Violence | 4 | 2023 | 11 | 2.620 |
Why?
|
Vaping | 7 | 2024 | 19 | 2.560 |
Why?
|
Adult | 54 | 2024 | 7598 | 2.420 |
Why?
|
Marijuana Abuse | 5 | 2021 | 40 | 2.260 |
Why?
|
Mental Disorders | 11 | 2020 | 280 | 2.030 |
Why?
|
Smoking Cessation | 12 | 2020 | 193 | 1.900 |
Why?
|
Legislation, Drug | 3 | 2024 | 10 | 1.880 |
Why?
|
Pregnancy Complications | 4 | 2020 | 196 | 1.860 |
Why?
|
California | 22 | 2024 | 2284 | 1.840 |
Why?
|
Self Report | 9 | 2022 | 251 | 1.780 |
Why?
|
Delivery of Health Care, Integrated | 7 | 2021 | 531 | 1.560 |
Why?
|
Young Adult | 23 | 2024 | 2427 | 1.470 |
Why?
|
Tobacco Products | 4 | 2021 | 17 | 1.420 |
Why?
|
Public Health | 4 | 2022 | 80 | 1.380 |
Why?
|
Cross-Sectional Studies | 15 | 2024 | 1322 | 1.310 |
Why?
|
Adolescent | 21 | 2024 | 3651 | 1.310 |
Why?
|
Tobacco Use Disorder | 4 | 2017 | 49 | 1.260 |
Why?
|
Male | 43 | 2024 | 10008 | 1.230 |
Why?
|
Smoke-Free Policy | 4 | 2017 | 6 | 1.220 |
Why?
|
Nicotine | 4 | 2022 | 47 | 1.210 |
Why?
|
Crime Victims | 3 | 2018 | 25 | 1.150 |
Why?
|
Middle Aged | 32 | 2024 | 7911 | 1.130 |
Why?
|
Life Change Events | 3 | 2018 | 31 | 1.110 |
Why?
|
Breast Feeding | 4 | 2021 | 133 | 1.080 |
Why?
|
Alcoholism | 6 | 2017 | 347 | 1.080 |
Why?
|
Counseling | 4 | 2020 | 189 | 1.030 |
Why?
|
Prevalence | 9 | 2024 | 884 | 1.000 |
Why?
|
Patient Acceptance of Health Care | 4 | 2020 | 382 | 1.000 |
Why?
|
Mental Health | 3 | 2022 | 165 | 0.990 |
Why?
|
United States | 20 | 2022 | 3956 | 0.970 |
Why?
|
Delivery of Health Care | 8 | 2022 | 415 | 0.970 |
Why?
|
Medical Marijuana | 2 | 2021 | 23 | 0.920 |
Why?
|
Tobacco Smoking | 2 | 2021 | 20 | 0.890 |
Why?
|
Anxiety Disorders | 3 | 2022 | 91 | 0.880 |
Why?
|
Methamphetamine | 1 | 2022 | 3 | 0.850 |
Why?
|
Cocaine | 1 | 2022 | 6 | 0.850 |
Why?
|
Qualitative Research | 1 | 2024 | 254 | 0.850 |
Why?
|
HIV Infections | 4 | 2021 | 694 | 0.830 |
Why?
|
Patient Protection and Affordable Care Act | 6 | 2020 | 42 | 0.800 |
Why?
|
Surveys and Questionnaires | 12 | 2022 | 1309 | 0.790 |
Why?
|
Child | 10 | 2022 | 2474 | 0.780 |
Why?
|
Adult Survivors of Child Abuse | 2 | 2012 | 6 | 0.760 |
Why?
|
Documentation | 2 | 2020 | 42 | 0.750 |
Why?
|
Alcohol-Related Disorders | 2 | 2012 | 55 | 0.750 |
Why?
|
Mass Screening | 4 | 2020 | 661 | 0.740 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 136 | 0.730 |
Why?
|
Anxiety | 3 | 2022 | 150 | 0.730 |
Why?
|
Insurance Coverage | 3 | 2020 | 106 | 0.730 |
Why?
|
Opioid-Related Disorders | 3 | 2017 | 167 | 0.710 |
Why?
|
Twins, Monozygotic | 3 | 2015 | 12 | 0.700 |
Why?
|
Stress, Psychological | 5 | 2022 | 141 | 0.700 |
Why?
|
Spouse Abuse | 2 | 2017 | 8 | 0.700 |
Why?
|
Consultants | 1 | 2019 | 1 | 0.700 |
Why?
|
Postnatal Care | 1 | 2019 | 21 | 0.690 |
Why?
|
Smoking Prevention | 2 | 2017 | 54 | 0.680 |
Why?
|
Drug Administration Routes | 1 | 2019 | 5 | 0.680 |
Why?
|
Electronic Health Records | 5 | 2020 | 681 | 0.670 |
Why?
|
Health Policy | 2 | 2018 | 122 | 0.660 |
Why?
|
Pandemics | 6 | 2023 | 287 | 0.650 |
Why?
|
Patient Participation | 2 | 2020 | 133 | 0.650 |
Why?
|
Mothers | 1 | 2019 | 105 | 0.640 |
Why?
|
Health Personnel | 1 | 2020 | 124 | 0.630 |
Why?
|
Cannabinoid Receptor Agonists | 3 | 2022 | 8 | 0.630 |
Why?
|
Sex Offenses | 1 | 2018 | 8 | 0.630 |
Why?
|
Longitudinal Studies | 11 | 2020 | 710 | 0.620 |
Why?
|
Adult Survivors of Child Adverse Events | 1 | 2018 | 4 | 0.610 |
Why?
|
Depression | 4 | 2022 | 502 | 0.610 |
Why?
|
Aged | 13 | 2021 | 6095 | 0.600 |
Why?
|
Depressive Disorder | 1 | 2020 | 222 | 0.590 |
Why?
|
Twins, Dizygotic | 2 | 2015 | 8 | 0.590 |
Why?
|
Risk Factors | 11 | 2019 | 3325 | 0.570 |
Why?
|
Tobacco Use Cessation | 1 | 2017 | 22 | 0.570 |
Why?
|
Medicaid | 2 | 2018 | 186 | 0.550 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2014 | 58 | 0.550 |
Why?
|
Health Communication | 1 | 2016 | 16 | 0.540 |
Why?
|
Retrospective Studies | 8 | 2022 | 2447 | 0.530 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 47 | 0.530 |
Why?
|
Guidelines as Topic | 1 | 2016 | 40 | 0.530 |
Why?
|
Social Environment | 3 | 2015 | 88 | 0.500 |
Why?
|
Socioeconomic Factors | 5 | 2024 | 630 | 0.500 |
Why?
|
Underage Drinking | 1 | 2015 | 6 | 0.500 |
Why?
|
Social Behavior | 1 | 2015 | 23 | 0.500 |
Why?
|
Attitude | 1 | 2015 | 30 | 0.490 |
Why?
|
Depressive Disorder, Major | 3 | 2013 | 124 | 0.480 |
Why?
|
Menthol | 1 | 2014 | 2 | 0.480 |
Why?
|
Prisons | 1 | 2015 | 29 | 0.480 |
Why?
|
Motivation | 4 | 2015 | 130 | 0.480 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 243 | 0.470 |
Why?
|
Diseases in Twins | 3 | 2013 | 15 | 0.470 |
Why?
|
Analgesics | 3 | 2022 | 27 | 0.460 |
Why?
|
Adaptation, Psychological | 2 | 2022 | 77 | 0.440 |
Why?
|
Taxes | 1 | 2013 | 24 | 0.430 |
Why?
|
Health Resources | 1 | 2013 | 37 | 0.430 |
Why?
|
Stress, Physiological | 1 | 2012 | 3 | 0.420 |
Why?
|
Health Surveys | 1 | 2013 | 260 | 0.410 |
Why?
|
Lung Neoplasms | 1 | 2016 | 255 | 0.410 |
Why?
|
San Francisco | 4 | 2015 | 64 | 0.380 |
Why?
|
Ethanol | 2 | 2022 | 22 | 0.380 |
Why?
|
Vitamins | 2 | 2022 | 64 | 0.380 |
Why?
|
Logistic Models | 5 | 2021 | 926 | 0.370 |
Why?
|
Attitude of Health Personnel | 2 | 2024 | 212 | 0.360 |
Why?
|
Postpartum Period | 2 | 2021 | 94 | 0.360 |
Why?
|
Sex Factors | 4 | 2017 | 643 | 0.350 |
Why?
|
Lactation | 2 | 2021 | 52 | 0.350 |
Why?
|
Tobacco Use | 2 | 2020 | 15 | 0.340 |
Why?
|
Child Abuse | 1 | 2010 | 43 | 0.330 |
Why?
|
Affect | 1 | 2009 | 25 | 0.330 |
Why?
|
Women's Health | 2 | 2022 | 200 | 0.330 |
Why?
|
Reproductive History | 1 | 2017 | 17 | 0.300 |
Why?
|
Breast Diseases | 1 | 2017 | 17 | 0.300 |
Why?
|
Calcinosis | 1 | 2017 | 40 | 0.300 |
Why?
|
Breast | 1 | 2017 | 84 | 0.290 |
Why?
|
Metabolic Syndrome | 1 | 2007 | 80 | 0.280 |
Why?
|
Sexual Partners | 2 | 2019 | 37 | 0.270 |
Why?
|
Postmenopause | 1 | 2017 | 241 | 0.270 |
Why?
|
Age of Onset | 4 | 2015 | 79 | 0.270 |
Why?
|
Mammography | 1 | 2017 | 169 | 0.270 |
Why?
|
Social Norms | 1 | 2024 | 3 | 0.240 |
Why?
|
Age Factors | 4 | 2014 | 917 | 0.230 |
Why?
|
Health Services Accessibility | 4 | 2020 | 289 | 0.220 |
Why?
|
Educational Status | 3 | 2020 | 200 | 0.220 |
Why?
|
Adolescent Behavior | 1 | 2024 | 127 | 0.210 |
Why?
|
Industry | 1 | 2022 | 1 | 0.210 |
Why?
|
Drug and Narcotic Control | 1 | 2022 | 5 | 0.210 |
Why?
|
Virginia | 2 | 2012 | 5 | 0.210 |
Why?
|
Prospective Studies | 3 | 2022 | 1267 | 0.210 |
Why?
|
Comorbidity | 4 | 2020 | 594 | 0.200 |
Why?
|
Motivational Interviewing | 1 | 2022 | 33 | 0.200 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 598 | 0.200 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2022 | 56 | 0.200 |
Why?
|
Cannabinoids | 1 | 2021 | 6 | 0.200 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 22 | 0.200 |
Why?
|
Preconception Care | 1 | 2022 | 43 | 0.190 |
Why?
|
Cannabidiol | 1 | 2021 | 1 | 0.190 |
Why?
|
Pilot Projects | 2 | 2019 | 218 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 375 | 0.190 |
Why?
|
Social Media | 1 | 2021 | 11 | 0.190 |
Why?
|
Pregnancy, Unwanted | 1 | 2020 | 7 | 0.180 |
Why?
|
Psychotic Disorders | 1 | 2021 | 44 | 0.180 |
Why?
|
Family | 2 | 2019 | 111 | 0.180 |
Why?
|
Intention | 1 | 2020 | 28 | 0.180 |
Why?
|
Workload | 1 | 2020 | 30 | 0.180 |
Why?
|
Self Medication | 1 | 2020 | 5 | 0.180 |
Why?
|
Psychological Trauma | 1 | 2020 | 6 | 0.180 |
Why?
|
International Agencies | 1 | 2019 | 1 | 0.170 |
Why?
|
Obstetrics | 1 | 2020 | 22 | 0.170 |
Why?
|
Coronavirus Infections | 1 | 2020 | 49 | 0.170 |
Why?
|
Skin Cream | 1 | 2019 | 3 | 0.170 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 56 | 0.170 |
Why?
|
Mentally Ill Persons | 2 | 2016 | 3 | 0.170 |
Why?
|
Plants, Edible | 1 | 2019 | 6 | 0.170 |
Why?
|
Palliative Care | 1 | 2020 | 57 | 0.170 |
Why?
|
Patient-Centered Care | 1 | 2021 | 197 | 0.170 |
Why?
|
Meaningful Use | 1 | 2018 | 5 | 0.160 |
Why?
|
Regression Analysis | 2 | 2017 | 297 | 0.160 |
Why?
|
Suicide | 1 | 2020 | 123 | 0.160 |
Why?
|
Aged, 80 and over | 3 | 2017 | 1900 | 0.160 |
Why?
|
Referral and Consultation | 1 | 2020 | 167 | 0.160 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 187 | 0.150 |
Why?
|
Infant, Newborn | 1 | 2021 | 844 | 0.150 |
Why?
|
Multivariate Analysis | 2 | 2017 | 568 | 0.150 |
Why?
|
Substance Abuse Detection | 1 | 2017 | 18 | 0.150 |
Why?
|
Feasibility Studies | 1 | 2018 | 114 | 0.150 |
Why?
|
Primary Health Care | 2 | 2021 | 766 | 0.150 |
Why?
|
Patient Admission | 1 | 2017 | 72 | 0.140 |
Why?
|
Tobacco Smoke Pollution | 2 | 2014 | 34 | 0.140 |
Why?
|
Natural Language Processing | 1 | 2017 | 57 | 0.140 |
Why?
|
Buprenorphine | 1 | 2017 | 48 | 0.140 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 351 | 0.140 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 93 | 0.140 |
Why?
|
Healthcare Disparities | 1 | 2018 | 201 | 0.130 |
Why?
|
Quality of Life | 1 | 2019 | 507 | 0.130 |
Why?
|
Cooking | 1 | 2015 | 17 | 0.130 |
Why?
|
Nutritional Sciences | 1 | 2015 | 11 | 0.130 |
Why?
|
Meals | 1 | 2015 | 7 | 0.130 |
Why?
|
Cohort Studies | 2 | 2020 | 2570 | 0.130 |
Why?
|
Twins | 2 | 2012 | 12 | 0.130 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 7 | 0.130 |
Why?
|
Multilevel Analysis | 1 | 2015 | 12 | 0.130 |
Why?
|
Gender Identity | 1 | 2015 | 36 | 0.120 |
Why?
|
Time Factors | 1 | 2018 | 1086 | 0.120 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2015 | 22 | 0.120 |
Why?
|
Cancer Survivors | 1 | 2016 | 83 | 0.120 |
Why?
|
Residence Characteristics | 2 | 2014 | 248 | 0.120 |
Why?
|
Environment | 1 | 2015 | 51 | 0.120 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 487 | 0.120 |
Why?
|
Hypertension | 1 | 2019 | 500 | 0.120 |
Why?
|
Decision Making | 1 | 2016 | 183 | 0.120 |
Why?
|
Feeding Behavior | 1 | 2015 | 166 | 0.120 |
Why?
|
Severity of Illness Index | 5 | 2015 | 454 | 0.120 |
Why?
|
Linear Models | 1 | 2015 | 231 | 0.120 |
Why?
|
Sex | 1 | 2014 | 2 | 0.120 |
Why?
|
Quality Improvement | 1 | 2016 | 189 | 0.120 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 358 | 0.120 |
Why?
|
Restaurants | 1 | 2014 | 17 | 0.120 |
Why?
|
Vocabulary | 1 | 2013 | 1 | 0.110 |
Why?
|
Memory | 1 | 2013 | 12 | 0.110 |
Why?
|
Minority Groups | 1 | 2014 | 101 | 0.110 |
Why?
|
Attention | 1 | 2013 | 10 | 0.110 |
Why?
|
Internet | 1 | 2015 | 231 | 0.110 |
Why?
|
Cotinine | 1 | 2013 | 7 | 0.110 |
Why?
|
Practice Patterns, Physicians' | 1 | 2016 | 330 | 0.110 |
Why?
|
Interpersonal Relations | 1 | 2013 | 42 | 0.110 |
Why?
|
Risk-Taking | 1 | 2014 | 109 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 748 | 0.110 |
Why?
|
Quinoxalines | 1 | 2012 | 12 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2010 | 125 | 0.110 |
Why?
|
Nicotinic Agonists | 1 | 2012 | 26 | 0.110 |
Why?
|
Benzazepines | 1 | 2012 | 24 | 0.110 |
Why?
|
Environmental Exposure | 1 | 2013 | 116 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2012 | 69 | 0.100 |
Why?
|
Twin Studies as Topic | 1 | 2011 | 3 | 0.100 |
Why?
|
Genetics, Behavioral | 1 | 2011 | 1 | 0.090 |
Why?
|
Schizotypal Personality Disorder | 1 | 2011 | 2 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 501 | 0.090 |
Why?
|
Genotype | 1 | 2011 | 227 | 0.090 |
Why?
|
Antisocial Personality Disorder | 1 | 2010 | 3 | 0.090 |
Why?
|
Child Abuse, Sexual | 1 | 2010 | 14 | 0.090 |
Why?
|
Registries | 1 | 2012 | 471 | 0.090 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2009 | 28 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 368 | 0.080 |
Why?
|
Odds Ratio | 1 | 2010 | 671 | 0.080 |
Why?
|
Arteries | 1 | 2017 | 8 | 0.080 |
Why?
|
Sweden | 1 | 2007 | 19 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 304 | 0.070 |
Why?
|
Survival Analysis | 1 | 2007 | 215 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 134 | 0.070 |
Why?
|
Health Behavior | 2 | 2018 | 359 | 0.060 |
Why?
|
Income | 2 | 2013 | 90 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 250 | 0.050 |
Why?
|
Florida | 1 | 2021 | 8 | 0.050 |
Why?
|
Infection Control | 1 | 2020 | 10 | 0.050 |
Why?
|
Prognosis | 1 | 2022 | 606 | 0.050 |
Why?
|
Vulnerable Populations | 1 | 2020 | 39 | 0.050 |
Why?
|
Psychometrics | 1 | 2020 | 121 | 0.040 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 105 | 0.040 |
Why?
|
Focus Groups | 1 | 2020 | 147 | 0.040 |
Why?
|
Pain | 1 | 2020 | 79 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2020 | 146 | 0.040 |
Why?
|
Alcoholic Intoxication | 1 | 2017 | 6 | 0.040 |
Why?
|
Binge Drinking | 1 | 2017 | 8 | 0.040 |
Why?
|
Opiate Substitution Treatment | 1 | 2017 | 44 | 0.030 |
Why?
|
Risk Assessment | 1 | 2020 | 1097 | 0.030 |
Why?
|
Nutritional Status | 1 | 2015 | 30 | 0.030 |
Why?
|
Transdermal Patch | 1 | 2015 | 1 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 438 | 0.030 |
Why?
|
Adolescent Health Services | 1 | 2015 | 43 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2017 | 1115 | 0.030 |
Why?
|
Set (Psychology) | 1 | 2013 | 1 | 0.030 |
Why?
|
Automobiles | 1 | 2013 | 2 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 38 | 0.030 |
Why?
|
Arousal | 1 | 2013 | 4 | 0.030 |
Why?
|
Mental Recall | 1 | 2013 | 31 | 0.030 |
Why?
|
Housing | 1 | 2013 | 39 | 0.030 |
Why?
|
Mental Health Services | 1 | 2015 | 154 | 0.030 |
Why?
|
Varenicline | 1 | 2012 | 13 | 0.030 |
Why?
|
Heart Diseases | 1 | 2013 | 77 | 0.030 |
Why?
|
Poverty | 1 | 2013 | 166 | 0.030 |
Why?
|
Population | 1 | 2011 | 3 | 0.020 |
Why?
|
Marital Status | 1 | 2011 | 21 | 0.020 |
Why?
|
Triplets | 1 | 2011 | 2 | 0.020 |
Why?
|
Personality | 1 | 2011 | 9 | 0.020 |
Why?
|
Models, Genetic | 1 | 2011 | 23 | 0.020 |
Why?
|
Los Angeles | 1 | 2011 | 139 | 0.020 |
Why?
|
Phenotype | 1 | 2011 | 149 | 0.020 |
Why?
|
Northern Ireland | 1 | 2010 | 1 | 0.020 |
Why?
|
Personality Inventory | 1 | 2010 | 14 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 12 | 0.020 |
Why?
|
Sampling Studies | 1 | 2010 | 51 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 30 | 0.020 |
Why?
|
Ethnic Groups | 1 | 2011 | 485 | 0.020 |
Why?
|
Concepts
(284)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->